Twelve months of isoniazid compared with four months of isoniazid and rifampin for persons with radiographic evidence of previous tuberculosis: an outcome and cost-effectiveness analysis. [electronic resource]
Producer: 20001214Description: 1648-52 p. digitalISSN:- 1073-449X
- Antitubercular Agents -- administration & dosage
- Cost-Benefit Analysis
- Drug Administration Schedule
- Drug Costs
- Drug Therapy, Combination
- Female
- Health Care Costs
- Humans
- Isoniazid -- administration & dosage
- Life Expectancy
- Male
- Middle Aged
- Outcome Assessment, Health Care
- Patient Compliance
- Radiography
- Recurrence
- Rifampin -- administration & dosage
- San Francisco
- Tuberculosis, Pulmonary -- diagnostic imaging
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.